Home Other Building Blocks 1H,2H,3H,5H,6H,7H,8H-cyclopenta[b]quinolin-9-amine hydrochloride

1H,2H,3H,5H,6H,7H,8H-cyclopenta[b]quinolin-9-amine hydrochloride

CAS No.:
90043-86-0
Catalog Number:
AG01AHB6
Molecular Formula:
C12H17ClN2
Molecular Weight:
224.7298
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01AHB6
Chemical Name:
1H,2H,3H,5H,6H,7H,8H-cyclopenta[b]quinolin-9-amine hydrochloride
CAS Number:
90043-86-0
Molecular Formula:
C12H17ClN2
Molecular Weight:
224.7298
MDL Number:
MFCD00517543
IUPAC Name:
2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine;hydrochloride
InChI:
InChI=1S/C12H16N2.ClH/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12;/h1-7H2,(H2,13,14);1H
InChI Key:
FERZJAONQGPFCU-UHFFFAOYSA-N
SMILES:
Nc1c2CCCCc2nc2c1CCC2.Cl
UNII:
107D610372
Properties
Complexity:
216  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
224.108g/mol
Formal Charge:
0
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
224.732g/mol
Monoisotopic Mass:
224.108g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
38.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
[Experience of joint administration of neuromidin and ovestin for correcting cognitive disorders in females with hypoestrogenic syndrome]. Eksperimental'naia i klinicheskaia farmakologiia 20101001
[Central mechanisms of therapeutic effectiveness of neuromidin in the treatment of peripheral nerve lesions]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[Selection of neuromethabolic drug in severe brain injury]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
Effect of neuromedin on activity of lactate dehydrogenase in mitochondrial fraction of the brain in rats with thermal injury. Bulletin of experimental biology and medicine 20080601
Effect of tacrine, amiridine, akatinol memantine, and triazolam on phosphorylation, structure, and assembly of microtubules from brain microtubular proteins in Alzheimer diseases. Bulletin of experimental biology and medicine 20080201
[The use of axamon in the complex rehabilitation of patients with movement disorders in the pathology of lumbar spine]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
[Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
[Current strategies of pathogenetic therapy of Alzheimer's disease]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20010101
Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia. Methods and findings in experimental and clinical pharmacology 19970501
Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. European journal of pharmacology 19931130
Properties